Valneva SE Valuation
| VALN Stock | USD 9.05 0.38 1.35% |
At this time, the company appears to be undervalued. Valneva SE ADR has a current Real Value of $10.5 per share. The regular price of the company is $8.65. Our model measures the value of Valneva SE ADR from inspecting the company fundamentals such as Return On Equity of -0.56, operating margin of (1.27) %, and Shares Outstanding of 85.92 M as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Valneva SE's price fluctuation is somewhat reliable at this time. Calculation of the real value of Valneva SE ADR is based on 3 months time horizon. Increasing Valneva SE's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Valneva SE is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Valneva Stock. However, Valneva SE's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.65 | Real 10.5 | Hype 8.63 |
The intrinsic value of Valneva SE's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Valneva SE's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Valneva SE ADR helps investors to forecast how Valneva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Valneva SE more accurately as focusing exclusively on Valneva SE's fundamentals will not take into account other important factors: Valneva SE Total Value Analysis
Valneva SE ADR is at this time expected to have valuation of 862.79 M with market capitalization of 772.02 M, debt of 216.31 M, and cash on hands of 336.22 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Valneva SE fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
862.79 M | 772.02 M | 216.31 M | 336.22 M |
Valneva SE Investor Information
The book value of the company was at this time reported as 0.83. The company recorded a loss per share of 1.51. Valneva SE ADR had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Valneva SE's historical financial statements, Valneva SE ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Valneva SE Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Valneva SE has an asset utilization ratio of 33.91 percent. This suggests that the Company is making $0.34 for each dollar of assets. An increasing asset utilization means that Valneva SE ADR is more efficient with each dollar of assets it utilizes for everyday operations.Valneva SE Ownership Allocation
Valneva SE ADR shows a total of 85.92 Million outstanding shares. About 93.86 % of Valneva SE outstanding shares are held by general public with 6.14 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Valneva SE Profitability Analysis
The company reported the previous year's revenue of 169.58 M. Net Loss for the year was (12.25 M) with loss before overhead, payroll, taxes, and interest of (3.69 M).About Valneva SE Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Valneva SE ADR. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Valneva SE ADR based exclusively on its fundamental and basic technical indicators. By analyzing Valneva SE's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Valneva SE's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Valneva SE. We calculate exposure to Valneva SE's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Valneva SE's related companies.Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on NASDAQ Exchange in the United States.
Valneva SE Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 70.3 M | |
| Forward Price Earnings | 666.6667 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.